These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38262082)

  • 1. Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
    Kadaikunnan S; Vijayaragavan P; Rathi MA; Balamuralikrishnan B; Alharbi NS; Gopalakrishnan VK; Purushothaman S; Sivanesan R
    J Infect Public Health; 2024 Mar; 17(3):450-456. PubMed ID: 38262082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial efficacy and membrane mechanism of action of the
    Decker T; Rautenbach M; Khan S; Khan W
    Microbiol Spectr; 2024 Jul; 12(7):e0295223. PubMed ID: 38842361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
    Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
    Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
    Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria.
    Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K
    J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation.
    Azmi F; Elliott AG; Marasini N; Ramu S; Ziora Z; Kavanagh AM; Blaskovich MA; Cooper MA; Skwarczynski M; Toth I
    Bioorg Med Chem; 2016 May; 24(10):2235-41. PubMed ID: 27048775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity.
    Shetty PR; Buddana SK; Tatipamula VB; Naga YV; Ahmad J
    Braz J Microbiol; 2014; 45(1):303-12. PubMed ID: 24948949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
    Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.
    Dugourd D; Yang H; Elliott M; Siu R; Clement JJ; Straus SK; Hancock RE; Rubinchik E
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3720-8. PubMed ID: 21576435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro antimicrobial susceptibility pattern of lipopeptide against drug resistant Vibrio species.
    Aljowaie RM; Abdel Gawwad MR; Al Farraj DA; H JK; Rajendran P
    J Infect Public Health; 2021 Dec; 14(12):1887-1892. PubMed ID: 34711526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial, anti-biofilm, and anti-proliferative activities of lipopeptide biosurfactant produced by Acinetobacter junii B6.
    Ohadi M; Forootanfar H; Dehghannoudeh G; Eslaminejad T; Ameri A; Shakibaie M; Adeli-Sardou M
    Microb Pathog; 2020 Jan; 138():103806. PubMed ID: 31629797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm eradication kinetics of the ultrashort lipopeptide C12 -OOWW-NH2 utilizing a modified MBEC Assay(™).
    Laverty G; Gorman SP; Gilmore BF
    Chem Biol Drug Des; 2015 May; 85(5):645-52. PubMed ID: 25264285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
    Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
    BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad-spectrum bactericidal lipopeptide with anti-biofilm properties.
    Meir O; Zaknoon F; Cogan U; Mor A
    Sci Rep; 2017 May; 7(1):2198. PubMed ID: 28526864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Activities of Lipopeptide (C
    Paduszynska MA; Maciejewska M; Greber KE; Sawicki W; Kamysz W
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Membrane Curvature Modulated Lipopeptide to Broadly Combat Multidrug-Resistant Bacterial Pneumonia with Low Resistance Risk.
    Zou P; Liu J; Li X; Yaseen M; Yao J; Liu L; Luo L; Wang H; Shi X; Li Z; Sun T; Gao Y; Gao C; Li LL
    ACS Nano; 2022 Dec; 16(12):20545-20558. PubMed ID: 36375012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and structural characterization of Coryxin, a novel cyclic lipopeptide from Corynebacterium xerosis NS5 having emulsifying and anti-biofilm activity.
    Dalili D; Amini M; Faramarzi MA; Fazeli MR; Khoshayand MR; Samadi N
    Colloids Surf B Biointerfaces; 2015 Nov; 135():425-432. PubMed ID: 26280817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.